Testing begins for a new form of PrEP

Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, Health, Human Health, Life Sciences, Medicine, Pharma, Pharmaceuticals, Politics, research, Science and Research, The Readout, vaccines

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Jason Mast here filling in for Elaine. We’ve got a dramatic vote on psychedelic therapy, record drug shortages, bad (maybe?) news for Biomarin, and a new kind of PrEP.

Read the rest…

Read Original Article: Testing begins for a new form of PrEP »

About The Author